D

Clover Health Investments, Corp. CLOV

$4.46 -$0.12-2.62% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$4.35$4.57
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

CLOV Rating

Reward
Risk

CLOV Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

CLOV Company Overview

Clover Health Investments, Corp. is a U.S.-based healthcare company focused on Medicare Advantage insurance and healthcare technology. The company operates primarily in the Medicare market, offering Medicare Advantage plans to seniors while also developing clinical software tools intended to improve care delivery and medical cost management. Clover Health’s core business has historically centered on insurance premium revenue generated through its Medicare Advantage membership base, supplemented by technology-enabled care management capabilities through its proprietary platform, Clover Assistant.

The company was founded in 2014 by Vivek Garipalli and Andrew Toy and later became publicly traded through a merger with a special purpose acquisition company sponsored by Social Capital Hedosophia in 2021. Clover Health positions itself as a technology-enabled payer focused on value-based care, using physician-facing software and data analytics to support earlier interventions, chronic disease management, and clinical decision-making. Its strategy has emphasized improving medical outcomes while lowering healthcare costs for Medicare beneficiaries, particularly in historically underserved populations.

Data compiled by narrative technology. May contain errors.
Sector

CLOV Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

CLOV Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

CLOV Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

CLOV Price History

Loading...
52-Week Range72% of range
Current
$4.46
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

CLOV Valuation

Market Cap
Market Cap Rank
#5,189
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

CLOV Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

CLOV Corporate Info

Phone Number
201 432 2133
Address
1209 Orange Street
Wilmington, DE 19801
Country
Year Founded

CLOV Filings

Filing Date
Friday, August 7, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

CLOV Headlines